Search
Cyclerion Therapeutics Inc
CYCNAdd to Watchlist
3.790USD
-0.200-5.01%
Close 08-28 16:00（ET）
16.17MMarket Cap
LossP/E TTM
TradingKey Chart
Intraday
1m
30m
1h
D
W
M
D
Today
-5.01%
5 Days
-2.57%
1 Month
+8.29%
6 Months
+180.74%
Year to Date
+198.43%
1 Year
+53.44%
Key Figures
3.990Open
4.270High
5.50KVolume
LossP/E TTM
LossP/E Dynamic
--Dividend TTM
0.13%Turnover Ratio
3.990Prev. Close
3.750Low
21.51KTurnover
LossP/E Static
3.18P/B
0.00%Div Yield TTM
-57.50%ROA
8.48052wk High
0.07Volume Ratio
-3.06MNet Profit
4.26MShares
-1.3055EPS TTM
1.80Beta
-67.77%ROE
1.02752wk Low
6.01%Amplitude
100.00%Gross Margin
16.17MMarket Cap
0.69Reward/Risk
20.61%Risk Rate
Gilead Sciences Inc Stock (GILD) Moved Up by 3.03% on Apr 1: Facts Behind the Movement
• Analysts express optimism with "Buy" ratings and high price targets. • Key products like Yeztugo show strong month-over-month sales growth. • Strategic acquisitions of Ouro Medicines and Arcellx enhance portfolios.
TradingKeyWed, Apr 1
AstraZeneca PLC Stock (AZN) Moved Up by 3.43% on Apr 1: Facts Behind the Movement
• AstraZeneca's tozorakimab showed positive Phase 3 results for COPD. • Analysts project $3-5 billion in annual revenue for tozorakimab. • Analysts maintain positive ratings and raise price targets for AstraZeneca.
TradingKeyWed, Apr 1
Eli Lilly and Co Stock (LLY) Moved Up by 5.46% on Apr 1: Facts Behind the Movement
• Eli Lilly to acquire Centessa Pharmaceuticals for up to $7.8 billion. • Acquisition expands neuroscience portfolio into sleep-wake disorders. • Analysts maintain "Buy" ratings with substantial upside price targets.
TradingKeyWed, Apr 1
Cyclerion Therapeutics Inc's Score
-0.23vs previous score
Forecast--
Financial Health8.54
Technical4.67
Valuation Dimensions7.87
Institutional Confidence3.00
Risk Assessment3.30
Media Coverage
Coverage Level
Very Low
Very High
Positive
Analyst Rating
Cyclerion Therapeutics Inc Technical Analysis
Technical Indicators
Strong sell
Summary
Sell
Moving Average
Neutral
Financial Indicators
Relevant data have not been disclosed by the company yet.
Relevant data have not been disclosed by the company yet.
Earnings
Next reporting date
--
Reporting Period
2026Q2
Earnings / Forecast
-0.41/--
Revenue / Forecast
0.00/--
Cyclerion Therapeutics Inc Profile
SectorBiotechnology & Medical Research
Ticker SymbolCYCN
Number of employees1
CountryUnited States of America
Ownership
| Shareholders | Proportion |
|---|---|
| Hecht (Peter M) | 12.91% |
| J. Wood Capital Advisors LLC | 4.20% |
| American Endowment Foundation | 3.07% |
| Invus Public Equities Advisors, LLC | 2.67% |
| Shareholder Types | Proportion |
|---|---|
| Individual Investor | 16.99% |
| Corporation | 7.27% |
| Investment Advisor | 4.23% |
| Hedge Fund | 1.69% |
Related Instruments
-0.13%
+0.85%
-1.11%
-1.03%
-0.80%
-0.54%
-1.05%
-2.14%
-0.21%
-1.41%
-1.07%
-0.55%
-0.04%
+0.32%
+1.09%
-1.67%
-3.37%
0.00%
-3.35%
-0.25%Popular Instruments
53555.200
+8.000 (+0.01%)
29453.100
-118.100 (-0.40%)
7712.900
-6.400 (-0.08%)
14639.000
-81.000 (-0.55%)
65815.000
-339.000 (-0.51%)
6476.100
+47.300 (+0.74%)
83.090
-0.176 (-0.21%)
319.700
+5.120 (+1.63%)
217.550
-10.430 (-4.57%)
4453.900
-146.790 (-3.19%)
FAQs
What is the current price of Cyclerion Therapeutics Inc (CYCN)?
The current price of Cyclerion Therapeutics Inc (CYCN) is 3.79.
What is the symbol of Cyclerion Therapeutics Inc?
The ticker symbol of Cyclerion Therapeutics Inc is CYCN.
What is the 52-week high of Cyclerion Therapeutics Inc?
The 52-week high of Cyclerion Therapeutics Inc is 8.48.
What is the 52-week low of Cyclerion Therapeutics Inc?
The 52-week low of Cyclerion Therapeutics Inc is 1.03.
What is the market capitalization of Cyclerion Therapeutics Inc?
The market capitalization of Cyclerion Therapeutics Inc is 16.17M.
What is the Earnings Per Share (EPS TTM) of Cyclerion Therapeutics Inc (CYCN)?
The Earnings Per Share (EPS TTM) of Cyclerion Therapeutics Inc (CYCN) is -1.31.